Prostate Specific Antigen Predicts the Long-Term Risk of Prostate Enlargement: Results from the Baltimore Longitudinal Study of Aging
- 1 June 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (6) , 2484-2487
- https://doi.org/10.1016/s0022-5347(05)65010-0
Abstract
Conclusions These data demonstrate the long-term risk of prostate enlargement by PSA level. Risk stratification based on PSA level may be useful to identify men at greatest risk for adverse events due to prostate enlargement and selection of men for future benign prostatic hyperplasia studies.Keywords
This publication has 7 references indexed in Scilit:
- SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2000
- Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasiaUrology, 1999
- Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasiaUrology, 1999
- Prostate Cancer Prevention Trial (PCPT) UpdateEuropean Urology, 1999
- Natural History of Prostatism: Risk Factors for Acute Urinary RetentionJournal of Urology, 1997
- Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men?Urology, 1995
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992